Caesarean and Corticotherapy
Sponsor
University Hospital, Strasbourg, France (Other)
Overall Status
Completed
CT.gov ID
NCT00446953
Collaborator
(none)
200
5
2
81
40
0.5
Study Details
Study Description
Brief Summary
Comparison of two randomized group :
-
caesarean section planned at 38 weeks after 2 antenatal injections of 12 mg of betamethasone 48 h before.
-
caesarean section planned at 39 weeks without corticosteroid.
The aim is to demonstrate that programming caesarean section at 38 weeks of pregnancy, after antenatal corticosteroid, allows to avoid caesarean section in emergency (because of a labour before 39 weeks), without increasing the neonatal respiratory distress rate.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 4 |
Study Design
Study Type:
Interventional
Actual Enrollment
:
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Interest in Programming Caesarean Section at 38 Weeks of Pregnancy With Antenatal Betamethasone to Prevent Neonatal Respiratory Distress and to Avoid Emergency Caesarean Section Before Planned Date.
Study Start Date
:
Feb 1, 2007
Actual Primary Completion Date
:
Oct 1, 2013
Actual Study Completion Date
:
Nov 1, 2013
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: 1 2x 12 mg betamethazone |
Drug: betamethasone
2x12 mg betamethazone c-section at 38 weeks
|
Placebo Comparator: 2 no drugs |
Other: placebo
c-section at 39 weeks
|
Outcome Measures
Primary Outcome Measures
- Neonatal respiratory distress [15 days]
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- woman who needs elective caesarean section
Exclusion Criteria:
-
multiple pregnancy
-
toxaemia
-
rhesus immunization
-
fetal infection
-
maternal gastro-duodenal ulcer
-
mother HIV+
-
prior injection of corticosteroid during the pregnancy
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Le Parc Centre pour la Mère et l'Enfant | Colmar | France | 68000 | |
2 | Centre Hospitalier de Haguenau | Haguenau | France | 67504 | |
3 | Hôpital de Hasenrain | Mulhouse | France | 68051 | |
4 | Cmco-Sihcus | Schiltigheim | France | 67303 | |
5 | Hôpital de Hautepierre | Strasbourg | France | 67000 |
Sponsors and Collaborators
- University Hospital, Strasbourg, France
Investigators
- Principal Investigator: Bruno Langer, MD, Les Hôpitaux Universitaires de Strasbourg
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
University Hospital, Strasbourg, France
ClinicalTrials.gov Identifier:
NCT00446953
Other Study ID Numbers:
- 3740
First Posted:
Mar 13, 2007
Last Update Posted:
Oct 14, 2015
Last Verified:
Sep 1, 2013
Keywords provided by University Hospital, Strasbourg, France
Additional relevant MeSH terms: